Johanniskraut Sidroga (Hypericum Perforatum)

Johanniskraut Sidroga is an herbal antidepressant that acts on mood‑regulating pathways.

• Mild to moderate depression: helps alleviate depressive symptoms in adults.
• Seasonal affective disorder: reduces mood swings associated with seasonal changes.
• Adjunctive mood support: can be used alongside other therapies to improve overall emotional wellbeing.

• Hypericum perforatum is thought to inhibit the reuptake of serotonin, dopamine, and norepinephrine, thereby increasing the availability of these neurotransmitters in synaptic clefts. The exact molecular mechanisms remain incompletely defined, but the combined effect on monoamine pathways is believed to contribute to its antidepressant activity.

Hypericum perforatum may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Gastrointestinal upset: nausea, stomach discomfort, or diarrhoea.
• Skin reactions: photosensitivity leading to sunburn‑like symptoms.
• Dizziness or headache.
• Fatigue or mild drowsiness.
• Dry mouth.

Serious or Rare Side Effects

• Serotonin syndrome when combined with other serotonergic agents.
• Severe allergic reactions such as rash, itching, or swelling.
• Hepatic enzyme induction leading to reduced efficacy of concurrent medications.
• Mood worsening or emergence of suicidal thoughts in rare cases.

When considering Johanniskraut Sidroga, several safety measures should be observed.

• Contraindication: avoid use in patients taking monoamine oxidase inhibitors or other serotonergic drugs.
• Pregnancy and breastfeeding: safety has not been established; consult a healthcare professional.
• Phototoxicity: advise patients to limit excessive sun exposure and use sunscreen.
• Drug interactions: review all concomitant medications for potential interactions.
• Monitoring: assess mood changes regularly, especially during the initial treatment period.
• Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Hypericum perforatum can affect the metabolism of several drugs, requiring careful management.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome.
• Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: heightened serotonin toxicity.
• Warfarin: may reduce anticoagulant effect, increasing clot risk.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: may lower hormonal efficacy, leading to unintended pregnancy.
• Cyclosporine and tacrolimus: possible reduction in immunosuppressant levels.
• Antiretrovirals (e.g., protease inhibitors): may decrease plasma concentrations.
• Anticonvulsants (e.g., carbamazepine): potential for reduced seizure control.